These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 37280407)
1. Total tumor volume as a predictor of survival in patients with multiple oligometastases treated with stereotactic ablative radiotherapy (SABR). Franzese C; Vernier V; Franceschini D; Comito T; Navarria P; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Marini B; Galdieri C; Mancosu P; Tomatis S; Scorsetti M J Cancer Res Clin Oncol; 2023 Sep; 149(12):10495-10503. PubMed ID: 37280407 [TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes of stereotactic ablative body radiotherapy on oligometastases from colorectal cancer: early results of a single institution service evaluation. Duong J; Stewart-Lord A; Nariyangadu P; Harrison M; Tsang YM BJR Open; 2022; 4(1):20210071. PubMed ID: 36105422 [TBL] [Abstract][Full Text] [Related]
3. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637 [TBL] [Abstract][Full Text] [Related]
4. Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial. Eufemon Cereno R; Mou B; Baker S; Chng N; Arbour G; Bergman A; Liu M; Schellenberg D; Matthews Q; Huang V; Mestrovic A; Hyde D; Alexander A; Carolan H; Hsu F; Miller S; Atrchian S; Chan E; Ho C; Mohamed I; Lin A; Berrang T; Bang A; Jiang W; Lund C; Pai H; Valev B; Lefresne S; Tyldesley S; Olson RA Radiother Oncol; 2023 May; 182():109576. PubMed ID: 36822355 [TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience. Armstrong S; Makris A; Belessiotis-Richards K; Abdul-Latif M; Ostler P; Shah N; Miles D; Tsang YM Clin Oncol (R Coll Radiol); 2024 Jun; 36(6):362-369. PubMed ID: 38575431 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy for pulmonary oligometastases: a monoinstitutional analysis of clinical outcomes and potential prognostic factors. Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Nicosia L; Ricchetti F; Rigo M; Attinà G; Vitale C; Pastorello E; Ruggieri R; Alongi F Strahlenther Onkol; 2022 Oct; 198(10):934-939. PubMed ID: 35499694 [TBL] [Abstract][Full Text] [Related]
7. Consolidative stereotactic ablative radiotherapy (SABR) to intrapulmonary lesions is associated with prolonged progression-free survival and overall survival in oligometastatic NSCLC patients: A prospective phase 2 study. Blake-Cerda M; Lozano-Ruíz F; Maldonado-Magos F; de la Mata-Moya D; Díaz-García D; Lara-Mejía L; Zatarain-Barrón ZL; Cuevas-Góngora MF; Barron-Barron F; Corona-Cruz JF; Cabrera-Miranda L; Arroyo-Hernández M; Gerson R; Arrieta O Lung Cancer; 2021 Feb; 152():119-126. PubMed ID: 33385737 [TBL] [Abstract][Full Text] [Related]
8. The impact of stereotactic ablative radiotherapy on oligoprogressive metastases from renal cell carcinoma. Franzese C; Marini B; Baldaccini D; Badalamenti M; Navarria P; Bellu L; Franceschini D; Comito T; Clerici E; Teriaca MA; Massaro M; Di Cristina L; Lo Faro L; Tomatis S; Scorsetti M J Cancer Res Clin Oncol; 2023 Jul; 149(8):4411-4417. PubMed ID: 36109401 [TBL] [Abstract][Full Text] [Related]
9. Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? Franzese C; Badalamenti M; Comito T; Franceschini D; Clerici E; Navarria P; Loi M; D'agostino G; Baldaccini D; Chiola I; Reggiori G; Mancosu P; Tomatis S; Scorsetti M Radiother Oncol; 2020 Sep; 150():184-190. PubMed ID: 32593644 [TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity. Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of stereotactic ablative radiotherapy in patients with oligometastatic hepatocellular carcinoma: A phase II study. Choi SH; Lee BM; Kim J; Kim DY; Seong J J Hepatol; 2024 Jul; 81(1):84-92. PubMed ID: 38467379 [TBL] [Abstract][Full Text] [Related]
12. A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study. Nicosia L; Franceschini D; Perrone-Congedi F; Molinari A; Gerardi MA; Rigo M; Mazzola R; Perna M; Scotti V; Fodor A; Iurato A; Pasqualetti F; Gadducci G; Chiesa S; Niespolo RM; Bruni A; Cappelli A; D'Angelo E; Borghetti P; Di Marzo A; Ravasio A; De Bari B; Sepulcri M; Aiello D; Mortellaro G; Sangalli C; Franceschini M; Montesi G; Aquilanti FM; Lunardi G; Valdagni R; Fazio I; Scarzello G; Vavassori V; Maranzano E; Maria Magrini S; Arcangeli S; Gambacorta MA; Valentini V; Paiar F; Ramella S; Di Muzio NG; Loi M; Jereczek-Fossa BA; Casamassima F; Osti MF; Scorsetti M; Alongi F Clin Transl Radiat Oncol; 2023 Mar; 39():100568. PubMed ID: 36935855 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of single fraction stereotactic ablative radiotherapy for lung metastases. Filippi AR; Badellino S; Guarneri A; Levis M; Botticella A; Mantovani C; Ragona R; Racca P; Buffoni L; Novello S; Ricardi U Technol Cancer Res Treat; 2014 Feb; 13(1):37-45. PubMed ID: 23819496 [TBL] [Abstract][Full Text] [Related]
14. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease. Salim N; Tumanova K; Popodko A; Libson E JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters. Tan H; Cheung P; Louie AV; Myrehaug S; Niglas M; Atenafu EG; Chu W; Chung HT; Poon I; Sahgal A; Soliman H Radiother Oncol; 2021 Aug; 161():159-165. PubMed ID: 34119585 [TBL] [Abstract][Full Text] [Related]
17. The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis. Jeong JU; Rim CH; Yoo GS; Cho WK; Chie EK; Ahn YC; Lee JH; Cancer Res Treat; 2024 Jul; 56(3):809-824. PubMed ID: 38097919 [TBL] [Abstract][Full Text] [Related]